X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/28/2853921/0/en/Cocrystal-Pharma-Reports-2023-Financial-Results-and-Provides-Updates-on-its-Antiviral-Drug-Development-Programs.html
https://www.globenewswire.com/news-release/2024/03/19/2848481/0/en/Cocrystal-Pharma-Receives-Pre-IND-Responses-from-the-FDA-on-Oral-CC-42344-for-Treating-Influenza-A.html
https://www.globenewswire.com//news-release/2024/01/04/2803963/0/en/Cocrystal-Pharma-Provides-an-Update-on-the-Clinical-Development-of-its-Novel-Broad-Spectrum-Antiviral-Investigational-Candidates.html
https://www.globenewswire.com/news-release/2023/12/06/2791721/0/en/Cocrystal-Pharma-Announces-First-Patient-In-for-Phase-2a-Human-Challenge-Study-Evaluating-Oral-CC-42344-in-Pandemic-and-Seasonal-Influenza-A.html
https://www.globenewswire.com//news-release/2023/11/29/2787694/0/en/Cocrystal-Pharma-Highlights-its-Novel-Inhaled-and-Oral-Influenza-A-Antiviral-CC-42344-at-the-World-Vaccine-Congress-West-Coast.html
https://www.globenewswire.com//news-release/2023/11/27/2786112/0/en/Cocrystal-Pharma-to-Present-at-the-NobleCon-19-Conference-on-December-4-2023.html
https://www.globenewswire.com//news-release/2023/11/13/2779026/0/en/Cocrystal-Pharma-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Updates-on-its-Antiviral-Drug-Development-Programs.html
https://www.globenewswire.com//news-release/2023/11/09/2777282/0/en/Cocrystal-Pharma-to-Discuss-Progress-with-Novel-Inhaled-and-Oral-Influenza-A-Antiviral-CC-42344-at-the-World-Vaccine-Congress-West-Coast.html
https://www.globenewswire.com//news-release/2023/10/31/2770088/0/en/Cocrystal-Pharma-Receives-UK-MHRA-Authorization-to-Initiate-Its-Phase-2a-Influenza-Human-Challenge-Trial-with-Oral-PB2-Inhibitor-CC-42344.html
https://www.globenewswire.com//news-release/2023/09/28/2751169/0/en/Cocrystal-Pharma-Doses-First-Subjects-in-Clinical-Study-of-CDI-988-For-Pandemic-Norovirus-and-Coronavirus.html
Market Place
Share 
